Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6978499 | 0.84 | RAB9A (0.43) | RAB9AHDAC1SMN1; SMN2HSD17B10POLB | |
| SCHEMBL24922409 | 0.80 | RAB9A (0.38) | RAB9AHDAC1SMN1; SMN2HSD17B10POLB | |
| SCHEMBL12227999 | 0.80 | DPP4 (0.57) | RAB9AHDAC1SMN1; SMN2HSD17B10POLB | |
| SCHEMBL6792599 | 0.79 | TAAR1 (0.43) | RAB9ASMN1; SMN2POLBALDH1A1TSHR | |
| SCHEMBL12669114 | 0.78 | HDAC1 (0.46) | RAB9AHDAC1HSD17B10POLBALDH1A1 | |
| SCHEMBL4369594 | 0.77 | TSHR (0.45) | RAB9ASMN1; SMN2HSD17B10POLBTDP1 | |
| SCHEMBL10987053 | 0.73 | RAB9A (0.48) | RAB9ASMN1; SMN2POLBTDP1ALDH1A1 | |
| SCHEMBL12669112 | 0.73 | HDAC1 (0.49) | HDAC1ALDH1A1GAAMAPT | |
| SCHEMBL10247599 | 0.73 | HPGD (0.53) | RAB9ASMN1; SMN2HSD17B10POLBALDH1A1 | |
| SCHEMBL10250866 | 0.73 | RAB9A (0.47) | RAB9AHDAC1SMN1; SMN2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250364597-A1 | ELECTROLYTE AND LITHIUM-ION BATTERIES | AESC JAPAN LTD. (JP) | 2025-11-27 | — | — | US | claimed |
| EP-4654312-A1 | ELECTROLYTE AND LITHIUM-ION BATTERIES | AESC Japan Ltd. (JP) | 2025-11-26 | — | — | EP | claimed |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-01-31 | — | — | US | claimed |
| US-20250364597-A1 | ELECTROLYTE AND LITHIUM-ION BATTERIES | AESC JAPAN LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| US-20250364597-A1 | ELECTROLYTE AND LITHIUM-ION BATTERIES | AESC JAPAN LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| WO-2025241164-A1 | ELECTROLYTE FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY COMPRISING ELECTROLYTE | 远景动力技术(鄂尔多斯市)有限公司 | 2025-11-27 | — | — | WO | disclosed |
| EP-4654312-A1 | ELECTROLYTE AND LITHIUM-ION BATTERIES | AESC Japan Ltd. (JP) | 2025-11-26 | — | — | EP | disclosed |
| EP-4654312-A1 | ELECTROLYTE AND LITHIUM-ION BATTERIES | AESC Japan Ltd. (JP) | 2025-11-26 | — | — | EP | disclosed |
| CN-115869926-B | Thienyl microsphere containing phosphonate functional group and preparation and application thereof | 中国科学院大连化学物理研究所 | 2025-01-24 | — | — | CN | disclosed |
| CN-115869926-A | Thienyl microsphere containing phosphonate functional group, preparation and application thereof | 中国科学院大连化学物理研究所 | 2023-03-31 | — | — | CN | disclosed |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| WO-1997028155-A1 | DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-07 | — | — | WO | disclosed |
| EP-0778284-A2 | New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | MERCK & CO. INC. (US) | 1997-06-11 | — | — | EP | disclosed |
| US-5510351-A | PREGNANE ENZYME INHIBITOR FOR TREATING SKIN DISORDER, BALDNESS, PROSTATIC CANCER | MERCK & CO., INC. (US) | 1996-04-23 | — | — | US | disclosed |
| EP-0646007-A4 | — | — | 1995-04-26 | — | — | EP | disclosed |
| EP-0646007-A1 | NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONES AS 5-g(a)-REDUCTASE INHIBITORS. | MERCK & CO INC (US) | 1995-04-05 | — | — | EP | disclosed |
| EP-0572166-A1 | New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors | MERCK & CO. INC. (US) | 1993-12-01 | — | — | EP | disclosed |
| WO-1993023050-A1 | NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| WO-1993023039-A1 | SUBSTITUTED 4-AZA-5A-ANDROSTAN-ONES AS 5A-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| WO-1993023420-A1 | NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | TST, SELENOI, SELE | RAB9A 3400/4885HDAC1 1047/4885SMN1; SMN2 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.